Back to top

Image: Shutterstock

Top Ranked Value Stocks to Buy for November 17th

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, November 17th:

Innoviva, Inc. (INVA - Free Report) : This company that engages in the development and commercialization of pharmaceuticals has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 24.3% over the last 60 days.

 

Innoviva, Inc. Price and Consensus

Innoviva, Inc. Price and Consensus

Innoviva, Inc. price-consensus-chart | Innoviva, Inc. Quote

 

Innoviva has a price-to-earnings ratio (P/E) of 4.94, compared with 14.50 for the industry. The company possesses a Value Score of A.

 

Innoviva, Inc. PE Ratio (TTM)

Innoviva, Inc. PE Ratio (TTM)

Innoviva, Inc. pe-ratio-ttm | Innoviva, Inc. Quote

 

United Natural Foods, Inc. (UNFI - Free Report) : This conventional grocery and non-food products provider has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising more than 100% over the last 60 days.

 

United Natural Foods has a price-to-earnings ratio (P/E) of 4.87, compared with 30.00 for the industry. The company possesses a Value Score of B.

 

Exantas Capital Corp. (XAN - Free Report) : This real estate investment trust has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 17.3% over the last 60 days.

 

Exantas Capital has a price-to-earnings ratio (P/E) of 3.99, compared with 7.80 for the industry. The company possesses a Value Score of A.

 

Green Plains Partners LP (GPP - Free Report) : This ethanol and fuel storage, terminal and transportation services provider has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 2.3% over the last 60 days.

 

Green Plains Partners has a price-to-earnings ratio (P/E) of 4.52, compared with 17.40 for the industry. The company possesses a Value Score of A.

 

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.

Legal Marijuana: An Investor’s Dream

Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027. 

Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.

Download Marijuana Moneymakers FREE >>